This is one of Geron's numerous patents covering not only composition of matter for various stem cells (licensed from WARF) but also methods of actually differentiating the cells into different other cells that are useful either potentially for therapy or for research use.
The current patent covers generation of endoderm through culturing of ES cells with Activin A and/or sodium butyrate.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.